Drug production process supervision platform
By analyzing basic data and harmful data in the production process of traditional Chinese medicine decoctions, judging abnormalities in raw materials and production processes, the problem of lack of ingredient detection and safety supervision in the existing technology is solved, and a more comprehensive and reliable abnormal analysis is achieved. and production safety.
Patent Information
- Application Number
- CN202411086969.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art lacks effective supervision of drug ingredients testing and production process safety in the production process of traditional Chinese medicine decoctions, resulting in a reduction in regulatory effect.
Provide a drug production process supervision platform, including data acquisition module, data analysis module, abnormality analysis module and abnormality processing module. By obtaining and analyzing the basic data and harmful data of traditional Chinese medicine decoctions, it judges the abnormal situation of raw materials and production processes, and Carry out early warning and automatically stop production.
The comprehensive and objective analysis of traditional Chinese medicine decoctions is achieved, the reliability and authenticity of abnormal situations are ensured, and the safety and regulatory effect of the production process are improved.
Smart Images

Figure CN119049669A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of production process supervision of traditional Chinese medicine decoctions, and specifically to a drug production process supervision platform. Background Art
[0002] With the development of science and technology, more and more production relies on machines, and Chinese herbal decoctions can also be mass-produced. However, the entire process of machine production cannot be fully covered by manual inspection, so it becomes very important to supervise the production process of Chinese herbal decoctions.
[0003] Prior art, such as the invention application patent with announcement number: CN116128272A, discloses a drug production process supervision platform, which includes: a process acquisition module, which acquires the production process for producing the target drug, and determines the sub-production image corresponding to each sub-generation process in the production process, and at the same time, determines the drug morphology image corresponding to each sub-production process of the target drug; a learning module, which performs a first learning on the sub-production image, and a second learning on the drug morphology image, and establishes a sub-monitoring model for monitoring the sub-production process; a model construction module, which acquires the production sequence of the production process, and associates each sub-monitoring model based on the production sequence of the production process, and constructs a comprehensive monitoring model based on the association results; a supervision module, which monitors the production process according to the comprehensive monitoring model, and generates a supervision report based on the monitoring results.
[0004] The present application provides a drug production process supervision platform, which solves the limitation problems existing in the current abnormal analysis process of Chinese herbal decoctions by analyzing the basic data and harmful data of Chinese herbal decoctions and then analyzing the abnormal situations of the basic data and harmful data of Chinese herbal decoctions. When the basic data or harmful data of Chinese herbal decoctions are abnormal, the raw material data is analyzed. If the raw materials are not abnormal, the abnormal situations of the production process of Chinese herbal decoctions are analyzed and judged, thereby achieving a comprehensive and objective analysis of Chinese herbal decoctions and ensuring the reliability and authenticity of the abnormal situation analysis results of Chinese herbal decoctions.
[0005] With respect to the above solution, the inventor of the present application has found that the above technology has at least the following technical problems:
[0006] 1. Currently, the above-mentioned technology mainly obtains the production process of the target drug, determines that each sub-production process corresponds to the drug morphology image of the target drug, establishes a sub-monitoring model for monitoring the sub-production process, and associates each sub-monitoring model based on the production sequence of the production process, and constructs a comprehensive monitoring model based on the association results; however, the production of drugs cannot rely solely on image monitoring, and the production process of Chinese herbal medicines cannot be supervised solely by image monitoring. There is a lack of detection of the finished drugs and the ingredients in the drugs. Images cannot measure the content of the ingredients in the drugs.
[0007] 2. Currently, there is a lack of further testing of the drug production process when abnormalities are found in the basic data and harmful data monitoring of drugs. The actual situation in the drug production process cannot be truly displayed, and thus the safety of drugs cannot be guaranteed, which reduces the regulatory effect of the drug production process to a certain extent. Summary of the invention
[0008] In view of the above-mentioned technical deficiencies, the purpose of this application is to provide a drug production process supervision platform.
[0009] In order to solve the above technical problems, the present application adopts the following technical solutions: The present application provides a drug production process supervision platform, comprising the following modules: a data acquisition module for acquiring basic data and harmful data of Chinese herbal decoctions.
[0010] The data analysis module includes a basic data analysis unit and a harmful data analysis unit.
[0011] The basic data analysis unit is used to analyze and obtain the basic data evaluation coefficient of the Chinese herbal decoction according to the basic data of the Chinese herbal decoction, and to determine whether the basic data of the Chinese herbal decoction is abnormal.
[0012] The harmful data analysis unit is used to analyze the harmful data in the Chinese herbal decoction to obtain the harmful data evaluation coefficient of the Chinese herbal decoction, and to determine whether the harmful data of the Chinese herbal decoction is abnormal.
[0013] The abnormality analysis module is used to obtain the raw material data of the Chinese herbal decoction when the basic data or harmful data of the Chinese herbal decoction is abnormal, and analyze the raw material data to determine whether the raw materials are abnormal. If the raw materials are not abnormal, the environmental data of the production workshop and the dirt data of the production equipment are obtained, and the production data evaluation coefficient of the Chinese herbal decoction is analyzed to determine whether the production process of the Chinese herbal decoction is abnormal.
[0014] The exception handling module is used to issue early warning prompts for raw materials when abnormalities occur in raw materials; when abnormalities occur in the production process of traditional Chinese medicine decoctions, production is stopped immediately, and cleaning prompts are issued for the production workshop and production equipment.
[0015] Preferably, the basic data of the Chinese herbal decoction include the content of each component and the pH value; the harmful data of the Chinese herbal decoction include the bacterial content, the heavy metal content and the botulinum toxin content.
[0016] Preferably, the raw material data of the Chinese herbal decoction is obtained, and the raw material data is analyzed to determine whether there is any abnormality in the raw materials. The specific analysis process is as follows: the raw material data corresponding to the Chinese herbal decoction is retrieved from the database, the raw material data including the gram weight of each component put into use when the Chinese herbal decoction is produced, and the storage environment value of each component; the gram weight ratio of each component is compared with the standard ratio of each component of the Chinese herbal decoction in the database, and the storage environment value of each component is checked; when the gram weight ratio of each component is different from the standard ratio of each component of the Chinese herbal decoction in the database or the storage environment value of a certain component does not fall within the standard range, it is determined that there is an abnormality in the raw materials; when the gram weight ratio of each component is the same as the standard ratio of each component of the Chinese herbal decoction in the database and the storage environment value of each component falls within the standard range, it is determined that there is no abnormality in the raw materials.
[0017] Preferably, the environmental data of the production workshop includes temperature, humidity and air cleanliness, and the dirt data of the production equipment includes dirt area and residue amount.
[0018] The beneficial effects of the present application are: 1. A drug production process supervision platform provided by the present application solves the limitation problems existing in the current abnormal analysis process of Chinese herbal decoctions by analyzing the basic data and harmful data of Chinese herbal decoctions, and then analyzing the abnormal situations of the basic data and harmful data of Chinese herbal decoctions. When the basic data or harmful data of Chinese herbal decoctions are abnormal, the raw material data is analyzed. If the raw materials are not abnormal, the abnormal situations of the production process of Chinese herbal decoctions are analyzed and judged, thereby realizing the comprehensive and objective analysis of Chinese herbal decoctions and ensuring the reliability and authenticity of the abnormal situation analysis results of Chinese herbal decoctions.
[0019] 2. This application analyzes the basic data and harmful data of the Chinese herbal decoction separately, and analyzes whether the basic data or the harmful data in the Chinese herbal decoction is abnormal; thereby more accurately understanding the actual situation of the current Chinese herbal decoction, while also ensuring the comprehensiveness and authenticity of the abnormal analysis process of the Chinese herbal decoction. When any one of the items is abnormal, it is judged that the Chinese herbal decoction is abnormal, thereby ensuring the reference and accuracy of the analysis results, and it is also impossible to provide a reliable basis for subsequent inspections.
[0020] 3. When the basic data or harmful data of the Chinese herbal decoction are abnormal, the present application first analyzes the gram weight ratio of each component. If there is no abnormality in the raw materials, further check the storage environment value of each component. When the storage environment value of a certain component does not fall within the standard range, it is judged that the raw material is abnormal, thereby obtaining the abnormal situation of the raw material; when there is no abnormality in the raw materials, analyze the data of the production workshop and production equipment, and analyze the abnormal situation of the Chinese herbal decoction more comprehensively. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0022] Figure 1 This is a schematic diagram of the system structure connection for this application. DETAILED DESCRIPTION
[0023] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0024] See also Figure 1 As shown, the present application provides a drug production process supervision platform, including a data acquisition module, a basic data analysis unit and a harmful data analysis unit of a data analysis module, an abnormality analysis module, and an abnormality handling module.
[0025] The data acquisition module is used to obtain the basic data and harmful data of Chinese herbal medicine decoctions.
[0026] In a specific example, the basic data of the Chinese herbal decoction includes the content of each component and the pH value; the harmful data of the Chinese herbal decoction includes the bacterial content, the heavy metal content and the botulinum toxin content.
[0027] It should be noted that the content of each component in the Chinese herbal decoction is detected by colorimetry, photometry or chromatography; the pH value of the Chinese herbal decoction is detected by a pH detector.
[0028] It should be noted that the heavy metal content in Chinese herbal decoctions includes lead, cadmium and mercury; the PCR method is used to detect the bacterial content in Chinese herbal decoctions; the atomic absorption spectrometry method is used to detect the heavy metal content in Chinese herbal decoctions; and the toxin detection kit is used to measure the botulinum toxin content in Chinese herbal decoctions.
[0029] The data analysis module includes a basic data analysis unit and a harmful data analysis unit;
[0030] The basic data analysis unit is used to analyze and obtain the basic data evaluation coefficient of the Chinese herbal decoction according to the basic data of the Chinese herbal decoction, and to determine whether the basic data of the Chinese herbal decoction is abnormal.
[0031] The harmful data analysis unit is used to analyze the harmful data in the Chinese herbal decoction to obtain the harmful data evaluation coefficient of the Chinese herbal decoction, and to determine whether the harmful data of the Chinese herbal decoction is abnormal.
[0032] In a specific example, the analysis obtains the basic data evaluation coefficient of the Chinese herbal decoction, and the specific analysis process is as follows: the content of each component and the pH value of the Chinese herbal decoction are recorded as C i and P, wherein i=1, 2, ..., n, i represents the number corresponding to the content of each component, n represents the total number of components, and n is a natural integer greater than or equal to 1.
[0033] According to the calculation formula The basic data evaluation coefficient λ of Chinese herbal decoction is obtained, where C i ′ represents the reference value of the content of the i-th component in the database, P′ and ΔP represent the reference value of the pH value and the allowable floating value of the pH value in the database, σ1 and σ2 represent the weight factors corresponding to the component content and the pH value of the traditional Chinese medicine decoction in the database, respectively.
[0034] It should be noted that 0<σ1≤1, 0<σ2≤1, σ1+σ2=1.
[0035] It should be noted that the weight factors corresponding to the component content of the Chinese herbal decoction and the weight factors corresponding to the pH value were obtained by factor analysis. First, the information of the weight factors of the component content of the Chinese herbal decoction and the pH value was condensed, and then the variance explanation rate after rotation was obtained, and the weight was obtained by dividing the cumulative variance explanation rate.
[0036] It should be noted that factor analysis is a well-known technology. It is a multivariate statistical analysis method that starts from studying the internal dependencies of variables and reduces some variables with intricate relationships to a few comprehensive factors; information concentration is expressed as calculating the median; the variance explanation rate is the amount of information extracted by the factor, and the variance explanation rate = characteristic root / total number of analysis items; the variance explanation rate after rotation is expressed as the variance explanation rate of the factor after maximum variance rotation.
[0037] In a specific example, the basic data of the Chinese herbal decoction is judged to be abnormal, and the specific judgment process is as follows: the basic data evaluation coefficient of the Chinese herbal decoction is compared with the basic data evaluation coefficient threshold in the database. When the basic data evaluation coefficient of the Chinese herbal decoction is greater than or equal to the basic data evaluation coefficient threshold in the database, it is judged that the basic data of the Chinese herbal decoction is abnormal; otherwise, it is judged that the basic data of the Chinese herbal decoction is not abnormal.
[0038] In a specific example, the analysis obtains the harmful data evaluation coefficient of the traditional Chinese medicine decoction, and the specific analysis process is as follows: the bacterial content, heavy metal content and botulinum toxin content of the traditional Chinese medicine decoction are recorded as X, Z and R respectively, and substituted into the calculation formula:
[0039] The harmful data assessment coefficient α of Chinese herbal decoction is obtained, where e is represented by a natural constant, X′, Z′ and R′ represent the reference value of the bacterial content, the reference value of the heavy metal content and the reference value of the botulinum toxin content of the Chinese herbal decoction in the database, respectively, ΔX and ΔZ represent the allowed floating value of the bacterial content and the allowed floating value of the heavy metal content of the Chinese herbal decoction in the database, respectively, ω1, ω2 and ω3 represent the weight factors corresponding to the bacterial content, the weight factors corresponding to the heavy metal content and the weight factors corresponding to the botulinum toxin content of the Chinese herbal decoction in the database, respectively.
[0040] It should be noted that 0<σ1≤1, 0<ω2≤1, ω1+ω2=1.
[0041] It should be noted that the calculation method of the weight factor corresponding to the bacterial content, the weight factor corresponding to the heavy metal content and the weight factor corresponding to the botulinum toxin content of the Chinese herbal decoction is the same as the calculation method of the weight factor corresponding to the ingredient content and the weight factor corresponding to the pH value of the above-mentioned Chinese herbal decoction.
[0042] In a specific example, the process of determining whether the harmful data of a Chinese herbal decoction is abnormal is as follows: comparing the harmful data evaluation coefficient of the Chinese herbal decoction with the harmful data evaluation coefficient threshold in a database; when the harmful data evaluation coefficient of the Chinese herbal decoction is greater than or equal to the harmful data evaluation coefficient threshold in the database, it is determined that the harmful data of the Chinese herbal decoction is abnormal; otherwise, it is determined that the harmful data of the Chinese herbal decoction is not abnormal.
[0043] The present application analyzes the basic data and harmful data of the Chinese herbal decoction separately, and analyzes whether the basic data or the harmful data in the Chinese herbal decoction is abnormal; thereby more accurately understanding the actual situation of the current Chinese herbal decoction, while also ensuring the comprehensiveness and authenticity of the abnormal analysis process of the Chinese herbal decoction. When any one of the items is abnormal, it is judged that the Chinese herbal decoction is abnormal, thereby ensuring the reference and accuracy of the analysis results, and it is also impossible to provide a reliable basis for subsequent inspections.
[0044] The abnormality analysis module is used to obtain the raw material data of the Chinese herbal decoction and analyze the raw material data to determine whether there is any abnormality in the raw materials when the basic data or harmful data of the Chinese herbal decoction is abnormal; if there is no abnormality in the raw materials, the environmental data of the production workshop and the dirt data of the production equipment are obtained, and the production data evaluation coefficient of the Chinese herbal decoction is analyzed to determine whether there is any abnormality in the production process of the Chinese herbal decoction.
[0045] In a specific example, the raw material data of the Chinese herbal decoction is obtained, and the raw material data is analyzed to determine whether there is any abnormality in the raw materials. The specific analysis process is as follows: the raw material data corresponding to the Chinese herbal decoction is retrieved from the database, the raw material data including the gram weight of each component used when the Chinese herbal decoction is produced, and the storage environment value of each component; the gram weight ratio of each component is compared with the standard ratio of each component of the Chinese herbal decoction in the database, and the storage environment value of each component is checked; when the gram weight ratio of each component is different from the standard ratio of each component of the Chinese herbal decoction in the database or the storage environment value of a component does not fall within the standard range, it is determined that there is an abnormality in the raw materials; when the gram weight ratio of each component is the same as the standard ratio of each component of the Chinese herbal decoction in the database and the storage environment value of each component falls within the standard range, it is determined that there is no abnormality in the raw materials.
[0046] It should be noted that the environmental values such as temperature and humidity are stored, and the temperature is obtained by a temperature sensor, and the humidity is obtained by a humidity sensor.
[0047] In a specific example, the environmental data of the production workshop includes temperature, humidity and air cleanliness, and the dirt data of the production equipment includes dirt area and residue amount.
[0048] It should be noted that the temperature is obtained by the temperature sensor and the humidity is obtained by the humidity sensor; the air cleanliness is expressed as the cleanliness level of the air and is obtained by the air quality monitoring instrument; the dirt area of the production equipment is expressed as the total dirt area inside and outside the equipment during the production process of Chinese herbal medicine decoctions, and the amount of residue is expressed as the amount of residue that may remain in the difficult-to-clean locations inside the production equipment.
[0049] In a specific example, the analysis obtains the production data evaluation coefficient of the Chinese herbal decoction, and the specific analysis process is as follows: the temperature, humidity and air cleanliness of the production workshop are recorded as W, S and K respectively, and the dirt area and the amount of residue of the production equipment are recorded as G and CZ respectively and substituted into the calculation formula: The production data evaluation coefficient β of Chinese herbal decoction is obtained, where W′, S′ and K′ represent the reference value of temperature, humidity and air cleanliness of the production workshop in the database, respectively; ΔW, ΔS and ΔK represent the allowable floating value of temperature, humidity and air cleanliness of the production workshop in the database, respectively; G′ and CZ′ represent the reference value of dirt area and the reference value of residue quantity of the production equipment in the database, respectively. It is expressed as the weight factors corresponding to the temperature, humidity and air cleanliness of the production workshop in the database, It is expressed as the weight factor corresponding to the fouling area and the amount of residue in the production equipment in the database.
[0050] It should be noted that
[0051] It should be noted that the calculation method of the weight factors corresponding to the temperature, humidity and air cleanliness of the production workshop and the weight factors corresponding to the dirt area and residue amount of the production equipment is the same as the calculation method of the weight factors corresponding to the ingredient content of the above-mentioned Chinese herbal decoction and the weight factors corresponding to the pH value.
[0052] In a specific example, the determination of whether the production process of a Chinese herbal decoction has any abnormality is as follows: comparing the production data evaluation coefficient of the Chinese herbal decoction with the production data evaluation coefficient threshold in a database; when the production data evaluation coefficient of the Chinese herbal decoction is greater than or equal to the production data evaluation coefficient threshold in the database, it is determined that the production process of the Chinese herbal decoction has any abnormality; otherwise, it is determined that the production process of the Chinese herbal decoction has no abnormality.
[0053] When an abnormality occurs in the basic data or harmful data of a Chinese herbal decoction, the present application first analyzes the gram weight ratio of each component. If there is no abnormality in the raw materials, the storage environment value of each component is further checked. When the storage environment value of a certain component does not fall within the standard range, it is determined that the raw material is abnormal, thereby obtaining the abnormal situation of the raw material. When there is no abnormality in the raw materials, the data of the production workshop and production equipment are analyzed to more comprehensively analyze the abnormal situation of the Chinese herbal decoction.
[0054] The exception handling module is used to issue early warning prompts for raw materials when abnormalities occur in raw materials; when abnormalities occur in the production process of traditional Chinese medicine decoctions, production is stopped immediately, and cleaning prompts are issued for the production workshop and production equipment.
[0055] The present application provides a drug production process supervision platform, which solves the limitation problems existing in the current abnormal analysis process of Chinese herbal decoctions by analyzing the basic data and harmful data of Chinese herbal decoctions and then analyzing the abnormal situations of the basic data and harmful data of Chinese herbal decoctions. When the basic data or harmful data of Chinese herbal decoctions are abnormal, the raw material data is analyzed. If the raw materials are not abnormal, the abnormal situations of the production process of Chinese herbal decoctions are analyzed and judged, thereby achieving a comprehensive and objective analysis of Chinese herbal decoctions and ensuring the reliability and authenticity of the abnormal situation analysis results of Chinese herbal decoctions.
[0056] The above contents are merely examples and explanations of the concept of the present application. The technical personnel in this technical field may make various modifications or additions to the described specific embodiments or replace them in a similar manner. As long as they do not deviate from the concept of the invention or exceed the scope defined in this specification, they should all fall within the scope of protection of the present application.
Claims
1. A drug production process supervision platform, characterized in that: include: Data acquisition module, used to obtain basic data and harmful data of traditional Chinese medicine decoction; The data analysis module includes a basic data analysis unit and a harmful data analysis unit; The basic data analysis unit is used to analyze the basic data of the Chinese herbal decoction to obtain the basic data evaluation coefficient of the Chinese herbal decoction, and to determine whether the basic data of the Chinese herbal decoction is abnormal; The harmful data analysis unit is used to analyze the harmful data in the Chinese herbal decoction to obtain the harmful data evaluation coefficient of the Chinese herbal decoction, and to determine whether the harmful data of the Chinese herbal decoction is abnormal; The abnormality analysis module is used to obtain the raw material data of the Chinese herbal medicine decoction when the basic data or harmful data of the Chinese herbal medicine decoction is abnormal, and analyze the raw material data to determine whether the raw material is abnormal; If there is no abnormality in the raw materials, obtain the environmental data of the production workshop and the dirt data of the production equipment, analyze and obtain the production data evaluation coefficient of the Chinese herbal decoction, and determine whether there is any abnormality in the production process of the Chinese herbal decoction; The exception handling module is used to issue early warning prompts when the raw materials are abnormal; When any abnormality occurs in the production process of Chinese herbal decoction, production should be stopped immediately and cleaning reminders should be given for the production workshop and production equipment.
2. A drug production process supervision platform according to claim 1, characterized in that: The basic data of the Chinese herbal decoction include the content of each component and the pH value; the harmful data of the Chinese herbal decoction include the bacterial content, heavy metal content and botulinum toxin content.
3. A drug production process monitoring platform according to claim 2, characterized in that: The analysis results in the basic data evaluation coefficient of Chinese herbal decoctions. The specific analysis process is as follows: The content of each component and pH value of the Chinese herbal medicine decoction are recorded as C i and P, where i = 1, 2, ..., n, i represents the number corresponding to the content of each component, n represents the total number of components, and n is a natural integer greater than or equal to 1; According to the calculation formula The basic data evaluation coefficient λ of Chinese herbal decoction is obtained, where C i ′ represents the reference value of the content of the i-th component in the database, P′ and ΔP represent the reference value of the pH value and the allowable floating value of the pH value in the database, σ1 and σ2 represent the weight factors corresponding to the component content and the pH value of the traditional Chinese medicine decoction in the database, respectively.
4. A drug production process monitoring platform according to claim 3, characterized in that: The specific judgment process of judging whether the basic data of the Chinese herbal medicine decoction is abnormal is as follows: The basic data evaluation coefficient of the Chinese herbal decoction is compared with the basic data evaluation coefficient threshold in the database. When the basic data evaluation coefficient of the Chinese herbal decoction is greater than or equal to the basic data evaluation coefficient threshold in the database, it is judged that the basic data of the Chinese herbal decoction is abnormal; otherwise, it is judged that the basic data of the Chinese herbal decoction is not abnormal.
5. The drug production process monitoring platform according to claim 4, characterized in that: The analysis results in the harmful data assessment coefficient of Chinese herbal decoctions. The specific analysis process is as follows: The bacterial content, heavy metal content and botulinum toxin content of the traditional Chinese medicine decoction are recorded as X, Z and R respectively, and substituted into the calculation formula: The harmful data assessment coefficient α of Chinese herbal decoction is obtained, where e is represented by a natural constant, X′, Z′ and R′ represent the reference value of the bacterial content, the reference value of the heavy metal content and the reference value of the botulinum toxin content of the Chinese herbal decoction in the database, respectively, ΔX and ΔZ represent the allowed floating value of the bacterial content and the allowed floating value of the heavy metal content of the Chinese herbal decoction in the database, respectively, ω1, ω2 and ω3 represent the weight factors corresponding to the bacterial content, the weight factors corresponding to the heavy metal content and the weight factors corresponding to the botulinum toxin content of the Chinese herbal decoction in the database, respectively.
6. A drug production process monitoring platform according to claim 5, characterized in that: The specific judgment process of judging whether the harmful data of the Chinese herbal medicine decoction is abnormal is as follows: The harmful data assessment coefficient of the Chinese herbal decoction is compared with the harmful data assessment coefficient threshold in the database. When the harmful data assessment coefficient of the Chinese herbal decoction is greater than or equal to the harmful data assessment coefficient threshold in the database, it is judged that the harmful data of the Chinese herbal decoction is abnormal; otherwise, it is judged that the harmful data of the Chinese herbal decoction is not abnormal.
7. A drug production process monitoring platform according to claim 6, characterized in that: The raw material data of the Chinese herbal decoction is obtained and analyzed to determine whether the raw materials are abnormal. The specific analysis process is as follows: The raw material data corresponding to the Chinese herbal decoction is retrieved from the database, the raw material data including the gram weight of each component used in the production of the Chinese herbal decoction, and the storage environment value of each component; the gram weight ratio of each component is compared with the standard ratio of each component of the Chinese herbal decoction in the database, and the storage environment value of each component is checked; when the gram weight ratio of each component is different from the standard ratio of each component of the Chinese herbal decoction in the database or the storage environment value of a component does not fall within the standard range, it is judged that the raw material is abnormal; when the gram weight ratio of each component is the same as the standard ratio of each component of the Chinese herbal decoction in the database and the storage environment value of each component is within the standard range, it is judged that there is no abnormality in the raw material.
8. The drug production process monitoring platform according to claim 7, characterized in that: The environmental data of the production workshop includes temperature, humidity and air cleanliness, and the dirt data of the production equipment includes dirt area and residue quantity.
9. A drug production process monitoring platform according to claim 8, characterized in that: The analysis results in the production data evaluation coefficient of Chinese herbal decoctions. The specific analysis process is as follows: The temperature, humidity and air cleanliness of the production workshop are recorded as W, S and K respectively, and the dirt area and residue amount of the production equipment are recorded as G and CZ respectively and substituted into the calculation formula: The production data evaluation coefficient β of Chinese herbal decoction is obtained, where W′, S′ and K′ represent the reference value of temperature, humidity and air cleanliness of the production workshop in the database, respectively; ΔW, ΔS and ΔK represent the allowable floating value of temperature, humidity and air cleanliness of the production workshop in the database, respectively; G′ and CZ′ represent the reference value of dirt area and the reference value of residue quantity of the production equipment in the database, respectively. It is expressed as the weight factors corresponding to the temperature, humidity and air cleanliness of the production workshop in the database, It is expressed as the weight factor corresponding to the fouling area and the amount of residue in the production equipment in the database.
10. A drug production process monitoring platform according to claim 9, characterized in that: The specific process of judging whether the production process of the Chinese medicine decoction is abnormal is as follows: The production data evaluation coefficient of the Chinese herbal decoction is compared with the production data evaluation coefficient threshold in the database. When the production data evaluation coefficient of the Chinese herbal decoction is greater than or equal to the production data evaluation coefficient threshold in the database, it is judged that there is an abnormality in the production process of the Chinese herbal decoction; otherwise, it is judged that there is no abnormality in the production process of the Chinese herbal decoction.
Citation Information
Patent Citations
Drug production process supervision platform
CN116128272A
Quality automatic detection method and system for food processing production line
CN117928647A
Medicine quality control method, system and equipment based on monascus
CN118350711A
Intelligent monitoring system for traditional Chinese medicine production
CN118446574A
Cited By
Intelligent supervision system and method based on cyclocarya paliurus and poria cocos pharmaceutical composition production
CN120108561A
